References
- Ahnfelt-Rønne I, Arrigoni-Martelli E. A new anti-inflammatory compound, timegadine (N-cyclohexyl-N-4-/2-methylquinolyl-N'-2-thiazolyl-guanidine), which inhibits both prostaglandin and 12-hydroxy-eicosatetraenoic acid (12HETE) formation. Biochem Pharmacol 1980; 29: 3265–9
- Bombardieri S, Cattani P, Ciabattoni G, et al. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol 1981; 73: 893–901
- Brodie M J, Parke A, Gordon D, Hensby C N. 6-oxo-prostaglandin F1α in inflammatory joint fluid. Clinical pharmacology of prostacyclin, P J Lewis, J O'Grady. Raven Press, New York 1981; 117–20
- Doumas B T. Standards for total serum protein assays—a collaborative study. Clin Chem 1975; 21: 1159–66
- Flower R J. Macrocortin and the antiphospholipase proteins. Advances in inflammation research, G Weissmann. Raven Press, New York 1984; 1–3
- Flower R J, Gryglewski R, Herbaczynska-Cedro K, Vane J R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nature (New Biol) 1972; 238: 104–6
- Gilman A G. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970; 67: 305–12
- Higgs G A, Moncada S, Vane J R. The mode of action of anti-inflammatory drugs which prevent the peroxidation of arachidonic acid. Clin Rheum Dis 1980; 61: 675–81
- Isomäki H, Martio J, Kaarela K, et al. Comparison of the analgesic effects of nine nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1984; 23: 61–5
- Lewis G P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull 1983; 39: 243–8
- Metz S A. Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am 1981; 65: 713–57
- Moilanen E, Seppälä E, Vapaatalo H. Effects of some antirheumatic drugs on cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism in human peripheral granulocytes in vitro. 6th International Conference on Prostaglandins and Related Compounds, FlorenceItaly, June, 3–61986, 384
- Mondaca S, Vane J R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979; 30: 293–31
- Piper P J. Formation and actions of leukotrienes. Physiol Rev 1984; 64: 744–61
- Robinson D R, Dayer J-M, Krane S M. Prostaglandins and their regulation in rheumatoid inflammation. Ann NY Acad Sci 1979; 332: 279–94
- Robinson D R, McGuire M B, Levine L. Prostaglandins in rheumatic diseases. Ann NY Acad Sci 1975; 256: 318–29
- Robinson H J, Granda J L. Prostaglandins in synovial inflammatory disease. Surg Forum 1974; 25: 426–7
- Salmon J A, Simmons P M, Palmer R MJ. A radioimmunoassay for leukotriene B4. Prostaglandins 1982; 24: 225–35
- Seppälä E, Laitinen O, Vapaatalo H. Comparative study of the effects of acetylsalicylic acid, indomethacin and paracetamol on metabolites of arachidonic acid in plasma, serum and urine in man. Int J Clin Pharm Res 1983; 3: 265–9
- Seppälä E, Pora O, Metsä-Ketelä T. A modified method for extraction and purification of Prostaglandins with resin XAD-2. Prostaglandins Leukotrienes Med 1984; 14: 235–41
- Shen T Y. Prostaglandin synthetase inhibitors. Anti-inflammatory drugs, J R Vane, S H Ferreira. Springer-Verlag, Berlin 1979; 305–417, Handb Exp Pharm 50/II
- Skrifvars B, Nissilä M. Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report. Scand J Rheumatol 1980; 9: 33–8
- Stefanovich V. Inhibition of 3′,5′-cyclic AMP phosphodiesterase with anti-inflammatory agents. Res Commun Chem Pathol Pharmacol 1974; 7: 573–82
- Tokunaga M, Ohuchi K, Yoshizawa S, Tsurufuji S, Rikimaru A, Wakamatsu E. Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1981; 40: 462–5
- Trang L E. Prostaglandins and inflammation. Semin Arthritis Rheum 1980; 9: 153–90
- Trang L E, Granström E, Lövgren O. Levels of prostaglandin F2α and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 1977; 6: 151–4
- Vapaatalo H, Parantainen J, Linden I-B, Hakkarainen H. Prostaglandins and vascular headache. Action of tolfenamic acid, a new anti-inflammatory analgesic, on migraine. Headache, New Vistas, F Sicuteri. Biochemical Press, Florence 1977; 287–300
- Wallis W J, Simkin P A. Antirheumatic drugs concentration in human synovial fluid and synovial tissue. Clin Pharmacokin 1983; 8: 496–522
- Williams T J. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull 1983; 39: 239–42